Recently, the 15th Philanthropy Festival and 2025 ESG Summit were held in Beijing. Yangtze River Pharmaceutical Group Co., Ltd. ( “YRPG” or “the Group” ) was awarded both the "2025 Model Enterprise for Responsibility in Healthcare" and the "2025 ESG Case of the Year" in recognition of its long-term commitment and practical initiatives in healthcare responsibility and public welfare.
The Philanthropy Festival, the country’s first festival themed “public welfare” and co-launched by mainstream public media, is organized by Syobserve and Gongyidaily in partnership with multiple media outlets. The event aims to promote the spirit of public welfare, advocate public welfare practices, and build a platform for in-depth dialogue and cross-sector cooperation. After 15 years of exploration and practice, the festival has evolved into the most influential annual event in China’s public welfare and philanthropy sector. This year’s edition attracted over 1,000 leaders from public welfare and business communities, experts, scholars, and media representatives to attend both online and offline.
Today, the pharmaceutical industry’s ESG development is defined by three major trends: globalized strategies empowered by technological innovation, smart digitalization driving green manufacturing, and compliant information disclosure. The industry’s strategic thinking is shifting from a linear “product-market” framework to an integrated “business-society-environment” ecosystem. Against this backdrop, as a leading pharmaceutical enterprise, YRPG has fully embedded the concept of sustainable development into daily operations. It has focused on building and refining its ESG governance and implementation mechanisms, making ESG a core engine for the brand to earn long-term trust.
Aligning with international ESG frameworks such as the UN Sustainable Development Goals (SDGs), and deeply integrating its corporate mission “Dedicated to exploring and advancing, committed to caring for all”, YRPG has innovatively developed its “CARING” ESG core strategy, which serves as the action blueprint for the Group’s ESG practices. Following the management logic of “Governance–Strategy–Risks and Opportunities–Objectives and Targets”, the Group has prioritized 25 material ESG topics, translated them into more than 300 specific management indicators, and assigned implementation responsibilities across all functional departments. This ensures that the concept of sustainable development is embedded in every business decision made by the Group.
These latest awards stand as a powerful testament to the Group’s long-standing commitment to sustainable development and corporate responsibility. Building on this milestone, YRPG will continue to be guided by its “CARING” strategy, embedding the DNA of sustainable development into every facet of its operations—from product R&D and technological innovation to strategic business decisions. The Group will remain steadfast in its mission to safeguard public health and protect the environment. Through more concrete actions that drive business for good and foster ecological sustainability, YRPG is committed to contributing its part to building a healthier and more sustainable world for all.